Kairax HA Filler Professional System
Multi-layer facial rejuvenation with 12-18 month persistence
Professional Overview
CE-certified hyaluronic acid dermal filler containing 24mg/ml cross-linked HA with 0.3% lidocaine. Features SmartAdapt™ Technology showing 92% patient satisfaction in clinical trials with ≤8% edema rate and 68% pain reduction. Ideal for 3D volumizing (220-250Pa G’ modulus) with persistence lasting 12-18 months based on injection depth. Manufactured under ISO 13485 certification with tripartite sterility validation.
Key Clinical Benefits
Advanced Longevity
12-18 month persistence based on injection depth with TriPhase™ Cross-linking technology
Optimized Comfort
0.3% lidocaine reduces procedure discomfort by 68% (VAS scale) for enhanced patient comfort
Minimal Side Effects
≤8% transient edema rate in Phase III trials (n=1,542) with SmartAdapt™ Technology
Precision Contouring
220-250Pa G’ modulus for natural tissue support in multi-layer facial restoration
Advanced Technology
TriPhase™ Cross-linking
BDDE Optimization: 85-92% HA preservation through patented cross-linking technology
3D Matrix: Structured network for prolonged duration & natural movement
SmartAdapt™ Technology
Clinical Performance: 92% patient satisfaction in trials
Formulation: pH-balanced (6.8-7.4) for optimal tissue compatibility
Viscosity Matrix
Fine (12-15 Pa·s)
Superficial dermal layering for fine lines
Deep (18-22 Pa·s)
Mid-to-deep dermal augmentation
Sub-Q (25-28 Pa·s)
Subcutaneous volume restoration
Packaging Specifications
Storage Information
- Maintain refrigerated storage at 2-8°C protected from light
- Do not freeze
Product Durability
- 24 months expiry when unopened
- Borosilicate glass syringe with elastomer plunger
Professional Administration Guide
Storage
Maintain refrigerated storage until use
Needle Selection
30G for Fine/Deep viscosity; 27G for Sub-Q
Technique
Apply retrograde linear threading method
Post-Injection
Massage with recommended pressure (0.3-0.5N/cm²)
Follow-Up
Schedule assessment at 14±2 days post-treatment
Requirements
Full product training required prior to administration
Important Clinical Notice
Kairax HA Filler is a CE-marked Class III medical device for professional use only. Results may vary based on individual tissue response and injection technique. Contraindicated in pregnancy, autoimmune disorders, or active infection sites. Full product training required prior to administration. Individual results may vary significantly – manage patient expectations appropriately.
Reviews
There are no reviews yet.